In vitro maturation of oocytes: an option for fertility preservation in women |
| |
Authors: | Grynberg M Hesters L Bénard J Trèves R Fanchin R Frydman R Frydman N |
| |
Affiliation: | a Service de gynécologie-obstétrique et médecine de la reproduction, hôpital Antoine-Béclère, AP-HP, 157, rue de la Porte-de-Trivaux, 92141 Clamart, France b Inserm, U782, université Paris-Sud, 92140 Clamart, France c Service de biologie de la reproduction, hôpital Antoine-Béclère, AP-HP, 92141 Clamart, France |
| |
Abstract: | Although female cancer incidence may be on rise, antineoplastic regimens have become more successful. As a result, an increasing number of women with cancer survive to endure the long-term consequences of chemotherapy. One of the most important long-term consequences of cancers treatments in young female is premature ovarian failure and infertility. Because of the increasing survival rates, many of these young women are seeking methods to preserve their fertility. Currently, embryo/oocytes cryoporeservation obtained after ovarian stimulation appears to provide the best fertility preservation option. However, patients may not have sufficient time to undergo ovarian stimulation prior to chemotherapy and/or the hormones used in ovarian stimulation are contra-indicated for estrogen-dependant tumors. In vitro maturation of oocytes (IVM) has been suggested to avoid ovarian stimulation and time requirement in patients with cancer, and can be combined with ovarian tissue cryobanking. In this review, we will discuss the position of IVM in the strategy of fertility preservation in young women. |
| |
Keywords: | Maturation in vitro Pré servation de la fertilité Cancer |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|